AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $109,000 | +67.7% | 3,184 | -24.6% | 0.00% | – |
Q2 2020 | $65,000 | +828.6% | 4,221 | +744.2% | 0.00% | – |
Q1 2020 | $7,000 | -96.9% | 500 | -92.7% | 0.00% | – |
Q4 2019 | $228,000 | +121.4% | 6,822 | +39.3% | 0.00% | – |
Q3 2019 | $103,000 | +14.4% | 4,897 | +12.2% | 0.00% | – |
Q2 2019 | $90,000 | +309.1% | 4,363 | +336.3% | 0.00% | – |
Q1 2019 | $22,000 | -40.5% | 1,000 | -34.0% | 0.00% | – |
Q4 2018 | $37,000 | +32.1% | 1,516 | +47.9% | 0.00% | – |
Q3 2018 | $28,000 | -39.1% | 1,025 | -40.9% | 0.00% | – |
Q2 2018 | $46,000 | +2.2% | 1,734 | +23.9% | 0.00% | – |
Q1 2018 | $45,000 | -15.1% | 1,400 | 0.0% | 0.00% | – |
Q4 2017 | $53,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|